Roche Discloses Patient Death in Alzheimer’s Trial
An elderly patient died in a clinical study of Roche Holding AG’s experimental treatment for Alzheimer’s disease, prompting ...
Revolutionize Brain Health: Pro-Social AI For Alzheimer’s Prevention
November is National Alzheimer's Awareness Month. An opportunity to start plan for pro-social AI as a way to proactively ...
Discovery Senior Living's SHINE(R) Memory Care Program Earns Third Recognition From the Alzheimer’s Association(R) Curriculum Review
Training for the proprietary program is aimed at implementing the latest evidenced-based approaches to dementia care amid the ...
cc.gatech.edu13d
CS Majors Win Hackathon with AI-powered App for Alzheimer's Patients
Second-year computer science (CS) majors and entrepreneurs Syed Husain and Vihaan Nagarkar developed MemoLens as participants ...
Neuroscience News10d
New Clues on Protein Fibrils Could Transform Alzheimer’s Research
A recent study reveals that a polymer called polyphosphate may stabilize fibrils, protein structures linked to Alzheimer's, ...
Business Insider4d
Promising Developments in Alector’s Alzheimer’s Treatments Drive Buy Rating
The trial’s design, which includes comprehensive biomarker analysis, aims to assess the impact on the amyloid signaling pathway and neuroinflammation, reinforcing Alector’s innovative approach in the ...
Business Wire11d
Personalized Neuromodulation Treatment Significantly Slowed Alzheimer’s Progression in 12-month Phase 2 Study, Meeting Primary and Key Secondary Endpoints
Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Al ...
NBC News9d
Alzheimer's researchers say brain stimulation device may slow symptoms
The only approved treatments for Alzheimer’s disease are medications with limited effectiveness and a risk of severe, sometimes deadly, side effects. That’s why scientists search for therapies ...
FierceBiotech11d
Noninvasive brain stimulation slows Alzheimer's disease in yearlong trial
As the world of neurodegenerative disease drug development continues to be roiled by controversies, one company has taken a ...
Positive Buy Rating Reaffirmed for Cognition Therapeutics Amid Promising Alzheimer’s Drug Data
Cognition Therapeutics (CGTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram ...
MassDevice12d
Cognito Therapeutics’ Alzheimer’s treatment reduces dependence score by 56%
Cognito Therapeutics announced that its Spectris treatment reduced the Alzheimer's Disease Dependence Score by over 50% in a ...
FierceBiotech12d
Roche sees rapid amyloid clearing in Alzheimer's study, adjusts protocol after patient death
Early data suggest Roche’s antibody may safely and quickly remove amyloid plaque for patients with Alzheimer’s disease, though the mid-stage study has been tied to one death. | Early data suggest ...